NPI: 1699070706 · BENTON, AR 72015 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 01/20/2011
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 01/20/2011 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 4,124 | $34K |
| 2019 | 8,939 | $51K |
| 2020 | 9,313 | $65K |
| 2021 | 10,820 | $71K |
| 2022 | 8,577 | $58K |
| 2023 | 2,560 | $24K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 18,232 | 941 | $68K |
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 13,527 | 1,126 | $53K |
| 82108 | 171 | 167 | $49K | |
| 83970 | 526 | 463 | $48K | |
| 82728 | 305 | 285 | $30K | |
| A4657 | Syringe, with or without needle, each | 1,069 | 1,005 | $17K |
| 83550 | 297 | 283 | $8K | |
| 83540 | 333 | 302 | $8K | |
| 85041 | 771 | 735 | $7K | |
| 85048 | 762 | 727 | $5K | |
| J1270 | Injection, doxercalciferol, 1 mcg | 5,920 | 530 | $3K |
| 82607 | 14 | 14 | $2K | |
| J1756 | Injection, iron sucrose, 1 mg | 2,224 | 566 | $2K |
| 82746 | 15 | 15 | $238.38 | |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 66 | 25 | $102.50 |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 88 | 52 | $0.00 |
| G0008 | Administration of influenza virus vaccine | 13 | 13 | $0.00 |